Overview
In conjunction with the International Clinical Trial Day (ICTD) 2024, Singapore Clinical Research Professionals (SCRP) is proud to host this forum, Data Centric Clinical Research. Join us on 23 May 2024 as we explore the wonders of research data in advancement of clinical research for our patients.
Mark your calendars and join us on May 23rd 2024, as SCRP celebrates International Clinical Trials Day!
International Clinical Trial Day (ICTD) honours the first clinical trial, led by James Lind in 1747 on sailors with scurvy. It is a day to celebrate as we recognise the incredible progress clinical trials play in improving patient care. It is also a day that we express gratitude to clinical research experts for their contributions to advancement of public health through their hard work!
Join us for this day dedicated to insightful discussions and networking opportunities with research professionals who contribute to the Singapore Clinical Research ecosystem. This year theme focuses on data centric clinical research, where we review the impact of data in patient centric clinical research, the benefits and challenges associated with data analytics and technology. Different stakeholders will be invited to share their experiences – from academic, public health and industry.
Do celebrate this day with us to raise awareness about clinical research as we encourage more people to get involved!
This event is free for SCRP members! If you're not yet a member, now's the perfect time to join our vibrant community! Sign up today at https://www.scrp.sg/ to secure your spot.
If you wish to attend the event as a non-member, a small fee of SGD40 (industry participant) or SGD 20 (academia participant) will be incurred.
After you have registered on this SGInnovate portal, please pay via PayNow to the following UEN:
UEN: T23SS0150A
Name: Clinical Research Professionals Association - Singapore
Do include your name and last 4 characters of ID card (e.g. 287G) in the comments field.
Thank you for your support.
Schedule
Date: 23 May 2024, Thursday
Time: 2:30 PM - 5:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: Ng Teng Feng Center for Healthcare Innovation Hall 2 18 Jln Tan Tock Seng, 308443
Speakers
Moderator's Profile:
Dr Yeo Jing Ping, Head, Transformation, George Clinical
Dr Jing Ping Yeo has more than 25 years of clinical research experience in the institution, pharmaceutical and CRO industries. She is currently the Head of Transformation in George Clinical. Until recently, she was the Vice President in Cytel and General Manager for Asia Pacific. Prior to joining Cytel, she was the Director for Research Integrity, Compliance and Ethics in SingHealth. She was previously the Corporate Vice President for PAREXEL International CRO and has also worked in Quintiles and Novo Nordisk. Jing Ping brings with her wealth of experience in all aspects of clinical development, including strategic planning, commercial, budget management, clinical operations, project management, biometrics, medical writing, medical affairs, quality management, audits, biobanking compliance, research integrity and IRB. She is currently the Chair of Steering Committee Member for the Singapore Chapter of Drug Information Association (DIA), Program Committee for DIA-Asia.
Speaker's Profile:
Dr Huren Sivaraj, CEO and Co-Founder, Oncoshot
Dr Huren is a medical oncologist who founded Oncoshot in 2018. Oncoshot is a first-in-class real-time aggregated insights sharing marketplace for clinical research stakeholders to plan and manage cancer trials. The company’s mission is to improve patient access to cutting-edge cancer research by addressing enterprise-level inefficiencies arising from a lack of real-time cancer population insights during clinical research planning. Oncoshot’s principles centre around providing academic and private cancer centres with security, privacy and control measures required for scalable insights sharing between hospitals and industry stakeholders. Its technology applies federated data systems, artificial intelligence, and machine learning to oncology patient data.
Speaker's Profile:
Dr Daniel Tan , Senior Consultant Medical Oncologist at Division of Medical Oncology, National Cancer Centre Singapore
Daniel Tan is a Senior Consultant Medical Oncologist at Division of Medical Oncology at National Cancer Centre Singapore. Besides being the Associate Professor (Tenure-Track) at Duke-NUS Medical School, he is the Head of Division of Clinical Trials and Epidemiological Sciences at NCCS and a Senior Clinician-Scientist at Genome Institute of Singapore. He has a specialist interest in thoracic, head and neck oncology and cancer drug development. His research work focuses on addressing the translational gap between basic science and clinical practice, improving our understanding of the determinants of response and resistance to targeted therapy and immunotherapy. He leads the Experimental Cancer Therapeutics Unit (ECRU) at NCCS, growing it to one of the largest phase 1 units in Asia. In addition, he chairs the Asian Thoracic Oncology Research Group and co-leads Asia Pacific Oncology Drug Development Consortium, that coordinate translational research and clinical trials in APAC.
